 | • レポートコード：QAF27656 • 出版社/出版日：QYResearch / 2021年4月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の住血吸虫症治療薬市場について種類別（プラジカンテル、オキサムニキン、その他）、用途別（S. haematobium、S. mansoni、S. japonicum、S. mekongi、S. intercalatum）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・住血吸虫症治療薬市場の概要 ・世界の主要地域別住血吸虫症治療薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の住血吸虫症治療薬市場規模2016-2021：種類別（プラジカンテル、オキサムニキン、その他） ・世界の住血吸虫症治療薬市場予測2012-2027：種類別（プラジカンテル、オキサムニキン、その他） ・世界の住血吸虫症治療薬市場規模2016-2021：用途別（S. haematobium、S. mansoni、S. japonicum、S. mekongi、S. intercalatum） ・世界の住血吸虫症治療薬市場予測2012-2027：用途別（S. haematobium、S. mansoni、S. japonicum、S. mekongi、S. intercalatum） ・住血吸虫症治療薬のアメリカ市場規模と予測2016-2021 ・住血吸虫症治療薬のヨーロッパ市場規模と予測2016-2021 ・住血吸虫症治療薬の中国市場規模と予測2016-2021 ・住血吸虫症治療薬の日本市場規模と予測2016-2021 ・住血吸虫症治療薬の東南アジア市場規模と予測2016-2021 ・住血吸虫症治療薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Shin Poong、Merck、Bayer、EIPICO、Chandra Bhagat Pharma、Taj Pharmaceuticals） ・住血吸虫症治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・住血吸虫症治療薬の市場動向・機会・課題 ・調査の結論 |
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
The global average price of Drugs for Schistosomiasis is in the decreasing trend, from 62 USD/K Units in 2011 to 57 USD/K Units in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.
Market Analysis and Insights: Global Drugs for Schistosomiasis Market
The global Drugs for Schistosomiasis market was valued at US$ 82 in 2020 and will reach US$ 102.8 million by the end of 2027, growing at a CAGR of 3.8% during 2022-2027.
Global Drugs for Schistosomiasis Scope and Market Size
The global Drugs for Schistosomiasis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drugs for Schistosomiasis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Praziquantel
Oxamniquine
Other
Segment by Application
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
The Drugs for Schistosomiasis market is analysed and market size information is provided by regions (countries). Segment by Application, the Drugs for Schistosomiasis market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
1 Drugs for Schistosomiasis Market Overview
1.1 Drugs for Schistosomiasis Product Scope
1.2 Drugs for Schistosomiasis Segment by Type
1.2.1 Global Drugs for Schistosomiasis Sales by Type (2016 & 2021 & 2027)
1.2.2 Praziquantel
1.2.3 Oxamniquine
1.2.4 Other
1.3 Drugs for Schistosomiasis Segment by Application
1.3.1 Global Drugs for Schistosomiasis Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 S. haematobium
1.3.3 S. mansoni
1.3.4 S. japonicum
1.3.5 S. mekongi
1.3.6 S. intercalatum
1.4 Drugs for Schistosomiasis Market Estimates and Forecasts (2016-2027)
1.4.1 Global Drugs for Schistosomiasis Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Drugs for Schistosomiasis Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Drugs for Schistosomiasis Price Trends (2016-2027)
2 Drugs for Schistosomiasis Estimates and Forecasts by Region
2.1 Global Drugs for Schistosomiasis Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Drugs for Schistosomiasis Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Drugs for Schistosomiasis Sales Market Share by Region (2016-2021)
2.2.2 Global Drugs for Schistosomiasis Revenue Market Share by Region (2016-2021)
2.3 Global Drugs for Schistosomiasis Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Drugs for Schistosomiasis Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Drugs for Schistosomiasis Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Drugs for Schistosomiasis Estimates and Projections (2016-2027)
2.4.2 Europe Drugs for Schistosomiasis Estimates and Projections (2016-2027)
2.4.3 China Drugs for Schistosomiasis Estimates and Projections (2016-2027)
2.4.4 Japan Drugs for Schistosomiasis Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Drugs for Schistosomiasis Estimates and Projections (2016-2027)
2.4.6 India Drugs for Schistosomiasis Estimates and Projections (2016-2027)
3 Global Drugs for Schistosomiasis Competition Landscape by Players
3.1 Global Top Drugs for Schistosomiasis Players by Sales (2016-2021)
3.2 Global Top Drugs for Schistosomiasis Players by Revenue (2016-2021)
3.3 Global Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drugs for Schistosomiasis as of 2020)
3.4 Global Drugs for Schistosomiasis Average Price by Company (2016-2021)
3.5 Manufacturers Drugs for Schistosomiasis Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Drugs for Schistosomiasis Market Size by Type
4.1 Global Drugs for Schistosomiasis Historic Market Review by Type (2016-2021)
4.1.1 Global Drugs for Schistosomiasis Sales Market Share by Type (2016-2021)
4.1.2 Global Drugs for Schistosomiasis Revenue Market Share by Type (2016-2021)
4.1.3 Global Drugs for Schistosomiasis Price by Type (2016-2021)
4.2 Global Drugs for Schistosomiasis Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Drugs for Schistosomiasis Sales Forecast by Type (2022-2027)
4.2.2 Global Drugs for Schistosomiasis Revenue Forecast by Type (2022-2027)
4.2.3 Global Drugs for Schistosomiasis Price Forecast by Type (2022-2027)
5 Global Drugs for Schistosomiasis Market Size by Application
5.1 Global Drugs for Schistosomiasis Historic Market Review by Application (2016-2021)
5.1.1 Global Drugs for Schistosomiasis Sales Market Share by Application (2016-2021)
5.1.2 Global Drugs for Schistosomiasis Revenue Market Share by Application (2016-2021)
5.1.3 Global Drugs for Schistosomiasis Price by Application (2016-2021)
5.2 Global Drugs for Schistosomiasis Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Drugs for Schistosomiasis Sales Forecast by Application (2022-2027)
5.2.2 Global Drugs for Schistosomiasis Revenue Forecast by Application (2022-2027)
5.2.3 Global Drugs for Schistosomiasis Price Forecast by Application (2022-2027)
6 North America Drugs for Schistosomiasis Market Facts & Figures
6.1 North America Drugs for Schistosomiasis Sales by Company
6.1.1 North America Drugs for Schistosomiasis Sales by Company (2016-2021)
6.1.2 North America Drugs for Schistosomiasis Revenue by Company (2016-2021)
6.2 North America Drugs for Schistosomiasis Sales Breakdown by Type
6.2.1 North America Drugs for Schistosomiasis Sales Breakdown by Type (2016-2021)
6.2.2 North America Drugs for Schistosomiasis Sales Breakdown by Type (2022-2027)
6.3 North America Drugs for Schistosomiasis Sales Breakdown by Application
6.3.1 North America Drugs for Schistosomiasis Sales Breakdown by Application (2016-2021)
6.3.2 North America Drugs for Schistosomiasis Sales Breakdown by Application (2022-2027)
7 Europe Drugs for Schistosomiasis Market Facts & Figures
7.1 Europe Drugs for Schistosomiasis Sales by Company
7.1.1 Europe Drugs for Schistosomiasis Sales by Company (2016-2021)
7.1.2 Europe Drugs for Schistosomiasis Revenue by Company (2016-2021)
7.2 Europe Drugs for Schistosomiasis Sales Breakdown by Type
7.2.1 Europe Drugs for Schistosomiasis Sales Breakdown by Type (2016-2021)
7.2.2 Europe Drugs for Schistosomiasis Sales Breakdown by Type (2022-2027)
7.3 Europe Drugs for Schistosomiasis Sales Breakdown by Application
7.3.1 Europe 137 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 137 Sales Breakdown by Application (2022-2027)
8 China Drugs for Schistosomiasis Market Facts & Figures
8.1 China Drugs for Schistosomiasis Sales by Company
8.1.1 China Drugs for Schistosomiasis Sales by Company (2016-2021)
8.1.2 China Drugs for Schistosomiasis Revenue by Company (2016-2021)
8.2 China Drugs for Schistosomiasis Sales Breakdown by Type
8.2.1 China Drugs for Schistosomiasis Sales Breakdown by Type (2016-2021)
8.2.2 China Drugs for Schistosomiasis Sales Breakdown by Type (2022-2027)
8.3 China Drugs for Schistosomiasis Sales Breakdown by Application
8.3.1 China 245 Sales Breakdown by Application (2016-2021)
8.3.2 China 245 Sales Breakdown by Application (2022-2027)
9 Japan Drugs for Schistosomiasis Market Facts & Figures
9.1 Japan Drugs for Schistosomiasis Sales by Company
9.1.1 Japan Drugs for Schistosomiasis Sales by Company (2016-2021)
9.1.2 Japan Drugs for Schistosomiasis Revenue by Company (2016-2021)
9.2 Japan Drugs for Schistosomiasis Sales Breakdown by Type
9.2.1 Japan Drugs for Schistosomiasis Sales Breakdown by Type (2016-2021)
9.2.2 Japan Drugs for Schistosomiasis Sales Breakdown by Type (2022-2027)
9.3 Japan Drugs for Schistosomiasis Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Drugs for Schistosomiasis Market Facts & Figures
10.1 Southeast Asia Drugs for Schistosomiasis Sales by Company
10.1.1 Southeast Asia Drugs for Schistosomiasis Sales by Company (2016-2021)
10.1.2 Southeast Asia Drugs for Schistosomiasis Revenue by Company (2016-2021)
10.2 Southeast Asia Drugs for Schistosomiasis Sales Breakdown by Type
10.2.1 Southeast Asia Drugs for Schistosomiasis Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Drugs for Schistosomiasis Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Drugs for Schistosomiasis Sales Breakdown by Application
10.3.1 Southeast Asia M Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Units Sales Breakdown by Application (2022-2027)
11 India Drugs for Schistosomiasis Market Facts & Figures
11.1 India Drugs for Schistosomiasis Sales by Company
11.1.1 India Drugs for Schistosomiasis Sales by Company (2016-2021)
11.1.2 India Drugs for Schistosomiasis Revenue by Company (2016-2021)
11.2 India Drugs for Schistosomiasis Sales Breakdown by Type
11.2.1 India Drugs for Schistosomiasis Sales Breakdown by Type (2016-2021)
11.2.2 India Drugs for Schistosomiasis Sales Breakdown by Type (2022-2027)
11.3 India Drugs for Schistosomiasis Sales Breakdown by Application
11.3.1 India Drugs for Schistosomiasis Sales Breakdown by Application (2016-2021)
11.3.2 India Drugs for Schistosomiasis Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Drugs for Schistosomiasis Business
12.1 Shin Poong
12.1.1 Shin Poong Corporation Information
12.1.2 Shin Poong Business Overview
12.1.3 Shin Poong Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Shin Poong Drugs for Schistosomiasis Products Offered
12.1.5 Shin Poong Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Business Overview
12.2.3 Merck Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck Drugs for Schistosomiasis Products Offered
12.2.5 Merck Recent Development
12.3 Bayer
12.3.1 Bayer Corporation Information
12.3.2 Bayer Business Overview
12.3.3 Bayer Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bayer Drugs for Schistosomiasis Products Offered
12.3.5 Bayer Recent Development
12.4 EIPICO
12.4.1 EIPICO Corporation Information
12.4.2 EIPICO Business Overview
12.4.3 EIPICO Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2016-2021)
12.4.4 EIPICO Drugs for Schistosomiasis Products Offered
12.4.5 EIPICO Recent Development
12.5 Chandra Bhagat Pharma
12.5.1 Chandra Bhagat Pharma Corporation Information
12.5.2 Chandra Bhagat Pharma Business Overview
12.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Products Offered
12.5.5 Chandra Bhagat Pharma Recent Development
12.6 Taj Pharmaceuticals
12.6.1 Taj Pharmaceuticals Corporation Information
12.6.2 Taj Pharmaceuticals Business Overview
12.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Products Offered
12.6.5 Taj Pharmaceuticals Recent Development
…
13 Drugs for Schistosomiasis Manufacturing Cost Analysis
13.1 Drugs for Schistosomiasis Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Drugs for Schistosomiasis
13.4 Drugs for Schistosomiasis Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Drugs for Schistosomiasis Distributors List
14.3 Drugs for Schistosomiasis Customers
15 Market Dynamics
15.1 Drugs for Schistosomiasis Market Trends
15.2 Drugs for Schistosomiasis Drivers
15.3 Drugs for Schistosomiasis Market Challenges
15.4 Drugs for Schistosomiasis Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Drugs for Schistosomiasis Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Drugs for Schistosomiasis Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Drugs for Schistosomiasis Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Drugs for Schistosomiasis Sales (M Units) by Region (2016-2021)
Table 5. Global Drugs for Schistosomiasis Sales Market Share by Region (2016-2021)
Table 6. Global Drugs for Schistosomiasis Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Drugs for Schistosomiasis Revenue Share by Region (2016-2021)
Table 8. Global Drugs for Schistosomiasis Sales (M Units) Forecast by Region (2022-2027)
Table 9. Global Drugs for Schistosomiasis Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Drugs for Schistosomiasis Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Drugs for Schistosomiasis Revenue Share Forecast by Region (2022-2027)
Table 12. Global Drugs for Schistosomiasis Sales (M Units) of Key Companies (2016-2021)
Table 13. Global Drugs for Schistosomiasis Sales Share by Company (2016-2021)
Table 14. Global Drugs for Schistosomiasis Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Drugs for Schistosomiasis Revenue Share by Company (2016-2021)
Table 16. Global Drugs for Schistosomiasis by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Schistosomiasis as of 2020)
Table 17. Global Drugs for Schistosomiasis Average Price (USD/K Units) of Key Company (2016-2021)
Table 18. Manufacturers Drugs for Schistosomiasis Manufacturing Sites and Area Served
Table 19. Manufacturers Drugs for Schistosomiasis Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Drugs for Schistosomiasis Sales (M Units) by Type (2016-2021)
Table 22. Global Drugs for Schistosomiasis Sales Share by Type (2016-2021)
Table 23. Global Drugs for Schistosomiasis Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Drugs for Schistosomiasis Price (USD/K Units) by Type (2016-2021)
Table 25. Global Drugs for Schistosomiasis Sales Share by Type (2022-2027)
Table 26. Global Drugs for Schistosomiasis Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Drugs for Schistosomiasis Revenue Share by Type (2022-2027)
Table 28. Global Drugs for Schistosomiasis Price (USD/K Units) by Type (2022-2027)
Table 29. Global Drugs for Schistosomiasis Sales (M Units) by Application (2016-2021)
Table 30. Global Drugs for Schistosomiasis Sales Share by Application (2016-2021)
Table 31. Global Drugs for Schistosomiasis Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Drugs for Schistosomiasis Price (USD/K Units) by Application (2016-2021)
Table 33. Global Drugs for Schistosomiasis Sales (M Units) by Application (2022-2027)
Table 34. Global Drugs for Schistosomiasis Sales Share by Application (2022-2027)
Table 35. Global Drugs for Schistosomiasis Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Drugs for Schistosomiasis Revenue Share by Application (2022-2027)
Table 37. Global Drugs for Schistosomiasis Price (USD/K Units) by Application (2022-2027)
Table 38. North America Drugs for Schistosomiasis Sales (M Units) by Company (2016-2021)
Table 39. North America Drugs for Schistosomiasis Sales Market Share by Company (2016-2021)
Table 40. North America Drugs for Schistosomiasis Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Drugs for Schistosomiasis Revenue Market Share by Company (2016-2021)
Table 42. North America Drugs for Schistosomiasis Sales by Type (2016-2021) & (M Units)
Table 43. North America Drugs for Schistosomiasis Sales Market Share by Type (2016-2021)
Table 44. North America Drugs for Schistosomiasis Sales by Type (2022-2027) & (M Units)
Table 45. North America Drugs for Schistosomiasis Sales Market Share by Type (2022-2027)
Table 46. North America Drugs for Schistosomiasis Sales by Application (2016-2021) & (M Units)
Table 47. North America Drugs for Schistosomiasis Sales Market Share by Application (2016-2021)
Table 48. North America Drugs for Schistosomiasis Sales by Application (2022-2027) & (M Units)
Table 49. North America Drugs for Schistosomiasis Sales Market Share by Application (2022-2027)
Table 50. Europe Drugs for Schistosomiasis Sales (M Units) by Company (2016-2021)
Table 51. Europe Drugs for Schistosomiasis Sales Market Share by Company (2016-2021)
Table 52. Europe Drugs for Schistosomiasis Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Drugs for Schistosomiasis Revenue Market Share by Company (2016-2021)
Table 54. Europe Drugs for Schistosomiasis Sales by Type (2016-2021) & (M Units)
Table 55. Europe Drugs for Schistosomiasis Sales Market Share by Type (2016-2021)
Table 56. Europe Drugs for Schistosomiasis Sales by Type (2022-2027) & (M Units)
Table 57. Europe Drugs for Schistosomiasis Sales Market Share by Type (2022-2027)
Table 58. Europe Drugs for Schistosomiasis Sales by Application (2016-2021) & (M Units)
Table 59. Europe Drugs for Schistosomiasis Sales Market Share by Application (2016-2021)
Table 60. Europe Drugs for Schistosomiasis Sales by Application (2022-2027) & (M Units)
Table 61. Europe Drugs for Schistosomiasis Sales Market Share by Application (2022-2027)
Table 62. China Drugs for Schistosomiasis Sales (M Units) by Company (2016-2021)
Table 63. China Drugs for Schistosomiasis Sales Market Share by Company (2016-2021)
Table 64. China Drugs for Schistosomiasis Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Drugs for Schistosomiasis Revenue Market Share by Company (2016-2021)
Table 66. China Drugs for Schistosomiasis Sales by Type (2016-2021) & (M Units)
Table 67. China Drugs for Schistosomiasis Sales Market Share by Type (2016-2021)
Table 68. China Drugs for Schistosomiasis Sales by Type (2022-2027) & (M Units)
Table 69. China Drugs for Schistosomiasis Sales Market Share by Type (2022-2027)
Table 70. China Drugs for Schistosomiasis Sales by Application (2016-2021) & (M Units)
Table 71. China Drugs for Schistosomiasis Sales Market Share by Application (2016-2021)
Table 72. China Drugs for Schistosomiasis Sales by Application (2022-2027) & (M Units)
Table 73. China Drugs for Schistosomiasis Sales Market Share by Application (2022-2027)
Table 74. Japan Drugs for Schistosomiasis Sales (M Units) by Company (2016-2021)
Table 75. Japan Drugs for Schistosomiasis Sales Market Share by Company (2016-2021)
Table 76. Japan Drugs for Schistosomiasis Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Drugs for Schistosomiasis Revenue Market Share by Company (2016-2021)
Table 78. Japan Drugs for Schistosomiasis Sales by Type (2016-2021) & (M Units)
Table 79. Japan Drugs for Schistosomiasis Sales Market Share by Type (2016-2021)
Table 80. Japan Drugs for Schistosomiasis Sales by Type (2022-2027) & (M Units)
Table 81. Japan Drugs for Schistosomiasis Sales Market Share by Type (2022-2027)
Table 82. Japan Drugs for Schistosomiasis Sales by Application (2016-2021) & (M Units)
Table 83. Japan Drugs for Schistosomiasis Sales Market Share by Application (2016-2021)
Table 84. Japan Drugs for Schistosomiasis Sales by Application (2022-2027) & (M Units)
Table 85. Japan Drugs for Schistosomiasis Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Drugs for Schistosomiasis Sales (M Units) by Company (2016-2021)
Table 87. Southeast Asia Drugs for Schistosomiasis Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Drugs for Schistosomiasis Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Drugs for Schistosomiasis Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Drugs for Schistosomiasis Sales by Type (2016-2021) & (M Units)
Table 91. Southeast Asia Drugs for Schistosomiasis Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Drugs for Schistosomiasis Sales by Type (2022-2027) & (M Units)
Table 93. Southeast Asia Drugs for Schistosomiasis Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Drugs for Schistosomiasis Sales by Application (2016-2021) & (M Units)
Table 95. Southeast Asia Drugs for Schistosomiasis Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Drugs for Schistosomiasis Sales by Application (2022-2027) & (M Units)
Table 97. Southeast Asia Drugs for Schistosomiasis Sales Market Share by Application (2022-2027)
Table 98. India Drugs for Schistosomiasis Sales (M Units) by Company (2016-2021)
Table 99. India Drugs for Schistosomiasis Sales Market Share by Company (2016-2021)
Table 100. India Drugs for Schistosomiasis Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Drugs for Schistosomiasis Revenue Market Share by Company (2016-2021)
Table 102. India Drugs for Schistosomiasis Sales by Type (2016-2021) & (M Units)
Table 103. India Drugs for Schistosomiasis Sales Market Share by Type (2016-2021)
Table 104. India Drugs for Schistosomiasis Sales by Type (2022-2027) & (M Units)
Table 105. India Drugs for Schistosomiasis Sales Market Share by Type (2022-2027)
Table 106. India Drugs for Schistosomiasis Sales by Application (2016-2021) & (M Units)
Table 107. India Drugs for Schistosomiasis Sales Market Share by Application (2016-2021)
Table 108. India Drugs for Schistosomiasis Sales by Application (2022-2027) & (M Units)
Table 109. India Drugs for Schistosomiasis Sales Market Share by Application (2022-2027)
Table 110. Shin Poong Corporation Information
Table 111. Shin Poong Description and Business Overview
Table 112. Shin Poong Drugs for Schistosomiasis Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 113. Shin Poong Drugs for Schistosomiasis Product
Table 114. Shin Poong Recent Development
Table 115. Merck Corporation Information
Table 116. Merck Description and Business Overview
Table 117. Merck Drugs for Schistosomiasis Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 118. Merck Drugs for Schistosomiasis Product
Table 119. Merck Recent Development
Table 120. Bayer Corporation Information
Table 121. Bayer Description and Business Overview
Table 122. Bayer Drugs for Schistosomiasis Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 123. Bayer Drugs for Schistosomiasis Product
Table 124. Bayer Recent Development
Table 125. EIPICO Corporation Information
Table 126. EIPICO Description and Business Overview
Table 127. EIPICO Drugs for Schistosomiasis Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 128. EIPICO Drugs for Schistosomiasis Product
Table 129. EIPICO Recent Development
Table 130. Chandra Bhagat Pharma Corporation Information
Table 131. Chandra Bhagat Pharma Description and Business Overview
Table 132. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 133. Chandra Bhagat Pharma Drugs for Schistosomiasis Product
Table 134. Chandra Bhagat Pharma Recent Development
Table 135. Taj Pharmaceuticals Corporation Information
Table 136. Taj Pharmaceuticals Description and Business Overview
Table 137. Taj Pharmaceuticals Drugs for Schistosomiasis Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 138. Taj Pharmaceuticals Drugs for Schistosomiasis Product
Table 139. Taj Pharmaceuticals Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Drugs for Schistosomiasis Distributors List
Table 143. Drugs for Schistosomiasis Customers List
Table 144. Drugs for Schistosomiasis Market Trends
Table 145. Drugs for Schistosomiasis Market Drivers
Table 146. Drugs for Schistosomiasis Market Challenges
Table 147. Drugs for Schistosomiasis Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Schistosomiasis Product Picture
Figure 2. Global Drugs for Schistosomiasis Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Drugs for Schistosomiasis Sales Market Share by Application in 2021 & 2027
Figure 6. S. haematobium Examples
Figure 7. S. mansoni Examples
Figure 8. S. japonicum Examples
Figure 9. S. mekongi Examples
Figure 10. S. intercalatum Examples
Figure 11. Global Drugs for Schistosomiasis Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Drugs for Schistosomiasis Sales Growth Rate (2016-2027) & (US$ Million)
Figure 13. Global Drugs for Schistosomiasis Sales (M Units) Growth Rate (2016-2027)
Figure 14. Global Drugs for Schistosomiasis Price Trends Growth Rate (2016-2027) (USD/K Units)
Figure 15. Global Drugs for Schistosomiasis Revenue Market Share by Region: 2016 VS 2021
Figure 16. Global Drugs for Schistosomiasis Revenue Market Share by Region: 2021 VS 2027
Figure 17. North America Drugs for Schistosomiasis Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. North America Drugs for Schistosomiasis Sales (M Units) Growth Rate (2016-2027)
Figure 19. Europe Drugs for Schistosomiasis Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. Europe Drugs for Schistosomiasis Sales (Million USD) Growth Rate (2016-2027)
Figure 21. China Drugs for Schistosomiasis Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. China Drugs for Schistosomiasis Sales (Million USD) and Growth Rate (2016-2027)
Figure 23. Japan Drugs for Schistosomiasis Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Japan Drugs for Schistosomiasis Sales (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Drugs for Schistosomiasis Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Drugs for Schistosomiasis Sales (Million USD) Growth Rate (2016-2027)
Figure 27. India Drugs for Schistosomiasis Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. India Drugs for Schistosomiasis Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Global 5 Largest Drugs for Schistosomiasis Players Market Share by Revenue in Drugs for Schistosomiasis: 2016 & 2020
Figure 30. Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 31. Global Drugs for Schistosomiasis Revenue Share by Type (2016-2021)
Figure 32. Global Drugs for Schistosomiasis Revenue Growth Rate by Type in 2016 & 2020
Figure 33. Global Drugs for Schistosomiasis Revenue Share by Application (2016-2021)
Figure 34. Global Drugs for Schistosomiasis Revenue Growth Rate by Application in 2016 & 2020
Figure 35. North America Drugs for Schistosomiasis Sales Market Share by Type in 2020
Figure 36. North America Drugs for Schistosomiasis Sales Market Share by Application in 2020
Figure 37. Europe Drugs for Schistosomiasis Sales Market Share by Type in 2020
Figure 38. Europe Drugs for Schistosomiasis Sales Market Share by Application in 2020
Figure 39. China Drugs for Schistosomiasis Sales Market Share by Type in 2020
Figure 40. China Drugs for Schistosomiasis Sales Market Share by Application in 2020
Figure 41. Japan Drugs for Schistosomiasis Sales Market Share by Type in 2020
Figure 42. Japan Drugs for Schistosomiasis Sales Market Share by Application in 2020
Figure 43. Southeast Asia Drugs for Schistosomiasis Sales Market Share by Type in 2020
Figure 44. Southeast Asia Drugs for Schistosomiasis Sales Market Share by Application in 2020
Figure 45. India Drugs for Schistosomiasis Sales Market Share by Type in 2020
Figure 46. India Drugs for Schistosomiasis Sales Market Share by Application in 2020
Figure 47. Key Raw Materials Price Trend
Figure 48. Manufacturing Cost Structure of Drugs for Schistosomiasis
Figure 49. Manufacturing Process Analysis of Drugs for Schistosomiasis
Figure 50. Drugs for Schistosomiasis Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
世界の掻痒治療薬市場規模・現状・予測（2021年-2027年） Transdermal drug delivery systems are the most preferred methods of delivering pruritus drugs. The majority of the pruritus drugs are available in semi-solid topical dosage forms, such as lotions, gels, and creams, which are easier to apply, are less painful, and provides faster action than other fo…- 世界の眼瞼炎薬市場規模・現状・予測（2021年-2027年） Blepharitis is one of the most common ocular conditions characterized by inflammation, scaling, reddening, and crusting of the eyelid. This condition may also cause burning, itching, or a grainy sensation when introducing foreign objects or substances to the eye. The development of novel drug formul…
- 世界の脊髄性筋萎縮症（SMA）治療薬市場規模・現状・予測（2021年-2027年） Spinal Muscular Atrophy (SMA), also known as spinal muscular atrophy, is a type of disease in which the degeneration of motor neurons in the anterior horn of the spinal cord leads to muscle weakness and muscular atrophy.The Spinal muscular atrophy drugs Can effectively alleviate the symptoms of the …
- 世界の気管支拡張症薬市場規模・現状・予測（2021年-2027年） Diagnosis methods of bacterial lung infections have several limitations, including failure to precisely recognize the cause of infection and inability to provide a full representation of the bacterial load present in the lungs. This has driven researchers to develop a new probe, which can detect bac…
- 世界の高脂血症治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hyperlipidemia Drugs Market The global Hyperlipidemia Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…